down arrow

Emmessar Biotech

  • Market Cap: Micro Cap
  • Industry: Chemicals
  • ISIN: INE634B01016
  • NSEID:
  • BSEID: 524768
INR
33.20
-0.79 (-2.32%)
BSENSE

Apr 11, 12:52 PM

BSE+NSE Vol: 4.43 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

4.43 k (732.71%) Volume

Shareholding (Dec 2024)

FII

0.00%

Held by 0 FIIs

DII

0.20%

Held by 0 DIIs

Promoter

59.53%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Chemicals

stock-summary
Market cap

INR 17 Cr (Micro Cap)

stock-summary
P/E

17.00

stock-summary
Industry P/E

41

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.86

stock-summary
Return on Equity

9.78%

stock-summary
Price to Book

2.19

Revenue and Profits (1 Year):
Net Sales:
0 Cr
(Quarterly Results - Dec 2024)
Net Profit:
0 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-22.79%
0%
-22.79%
1 Year
-14.89%
0%
-14.89%
2 Years
27.74%
0%
27.74%
3 Years
-15.95%
0%
-15.95%
4 Years
91.46%
0%
91.46%
5 Years
207.41%
0%
207.41%

Emmessar Biotech for the last several years.

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-25.92%
EBIT Growth (5y)
-19.41%
EBIT to Interest (avg)
-0.43
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.47
Tax Ratio
46.88%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.20%
ROCE (avg)
-38.73%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
17
Industry P/E
41
Price to Book Value
2.19
EV to EBIT
-9.31
EV to EBITDA
-10.03
EV to Capital Employed
9.22
EV to Sales
10.33
PEG Ratio
0.55
Dividend Yield
NA
ROCE (Latest)
-92.86%
ROE (Latest)
9.78%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 2 Schemes (0.05%)

FIIs

Held by 0 FIIs

Promoter with highest holding

Emmessar Technologies Limited (21.79%)

Highest Public shareholder

Sandeep Rao (1.99%)

Individual Investors Holdings

37.09%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -70.59% vs 325.00% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -92.86% vs 211.11% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.10",
          "val2": "0.34",
          "chgp": "-70.59%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.28",
          "val2": "-0.08",
          "chgp": "-250.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.02",
          "val2": "0.28",
          "chgp": "-92.86%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-280.00%",
          "val2": "-23.53%",
          "chgp": "-256.47%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 180.00% vs -46.43% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 48.00% vs -24.24% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.42",
          "val2": "0.15",
          "chgp": "180.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.35",
          "val2": "-0.49",
          "chgp": "28.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.37",
          "val2": "0.25",
          "chgp": "48.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-83.33%",
          "val2": "-326.67%",
          "chgp": "243.34%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 8.33% vs -32.39% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 2.63% vs 22.58% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.52",
          "val2": "0.48",
          "chgp": "8.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.63",
          "val2": "-0.70",
          "chgp": "10.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.39",
          "val2": "0.38",
          "chgp": "2.63%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-121.15%",
          "val2": "-145.83%",
          "chgp": "24.68%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is -45.10% vs 183.33% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 50.00% vs 4.17% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.56",
          "val2": "1.02",
          "chgp": "-45.10%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.07",
          "val2": "-0.69",
          "chgp": "-55.07%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.75",
          "val2": "0.50",
          "chgp": "50.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-191.07%",
          "val2": "-67.65%",
          "chgp": "-123.42%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
0.10
0.34
-70.59%
Operating Profit (PBDIT) excl Other Income
-0.28
-0.08
-250.00%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
0.02
0.28
-92.86%
Operating Profit Margin (Excl OI)
-280.00%
-23.53%
-256.47%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is -70.59% vs 325.00% in Sep 2024

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Dec 2024 is -92.86% vs 211.11% in Sep 2024

Half Yearly Results Snapshot (Standalone) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
0.42
0.15
180.00%
Operating Profit (PBDIT) excl Other Income
-0.35
-0.49
28.57%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
0.37
0.25
48.00%
Operating Profit Margin (Excl OI)
-83.33%
-326.67%
243.34%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 180.00% vs -46.43% in Sep 2023

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2024 is 48.00% vs -24.24% in Sep 2023

Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
0.52
0.48
8.33%
Operating Profit (PBDIT) excl Other Income
-0.63
-0.70
10.00%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
0.39
0.38
2.63%
Operating Profit Margin (Excl OI)
-121.15%
-145.83%
24.68%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 8.33% vs -32.39% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is 2.63% vs 22.58% in Dec 2023

Annual Results Snapshot (Standalone) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
0.56
1.02
-45.10%
Operating Profit (PBDIT) excl Other Income
-1.07
-0.69
-55.07%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
0.75
0.50
50.00%
Operating Profit Margin (Excl OI)
-191.07%
-67.65%
-123.42%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is -45.10% vs 183.33% in Mar 2023

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2024 is 50.00% vs 4.17% in Mar 2023

stock-summaryCompany CV
About Emmessar Biotech & Nutrition Ltd stock-summary
stock-summary
Emmessar Biotech & Nutrition Ltd
Micro Cap
Chemicals
Emmessar Biotech & Nutrition Limited, originally established on 17th March 1992 as Emmessar Chemical Industries Ltd (ECIL) started its operations in manufacturing Super Specialty Fine Chemicals. The Company has so far, succeeded in developing many Specialty Fine Chemicals. ECIL gained official recognition for its R&D from DSIR, Ministry of Science & Technology, Government of India, New-Delhi in early 1996.
Company Coordinates stock-summary
Company Details
Plot No T-3/2 MIDC Area, P O Box No 39 Taloja Raigad Maharashtra : 410208
stock-summary
Tel: 91-022-20870587
stock-summary
investors@ebnl.co.in/emmessar@vsnl.
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai